FLI1 Knockout cell line (BEAS-2B)
Catalog Number: KOA31331
Price: Online Inquiry
Catalog Number: KOA31331
Price: Online Inquiry
| Product Information | |
|---|---|
| Product Name | FLI1 Knockout cell line (BEAS-2B) |
| specification | 1*10^6 |
| Storage and transportation | Shipped on dry ice; Store in liquid nitrogen |
| Cell morphology | Epithelial-like, adherent |
| Passage ratio | 1:3~1:4 |
| species | Human |
| Gene | FLI1 |
| Gene ID | 2313 |
| Build method | Electroporation/Lentivirus |
| Mycoplasma testing | negative |
| Cultivation system | 90% DMEM+10% FBS |
| Parental Cell Line | BEAS-2B |
| Quality Control | Genotype: FLI1 Knockout cell line (BEAS-2B)>95% viability before freezing. All cells were tested and found to be free of bacterial, viruses,mycoplasma and other toxins. |
| Gene Information | |
|---|---|
| Gene Official Full Name | Fli-1 proto-oncogene, ETS transcription factorprovided by HGNC |
| Also known as | EWSR2; FLI-1; SIC-1; BDPLT21 |
| Gene Description | This gene encodes a transcription factor containing an ETS DNA-binding domain. The gene can undergo a t(11;22)(q24;q12) translocation with the Ewing sarcoma gene on chromosome 22, which results in a fusion gene that is present in the majority of Ewing sarcoma cases. An acute lymphoblastic leukemia-associated t(4;11)(q21;q23) translocation involving this gene has also been identified. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2012] |
| Expression | Broad expression in spleen (RPKM 33.9), lymph node (RPKM 17.6) and 20 other tissues See more |
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
|
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.